EUVIMEDEUVIMED entdecken
Crossref

Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition

Yun Wang, Jinling Wang iD, Roumei Ye, Quanyi Jin, Fengyue Yin, Nian Liu, Yubo Wang, Quan Zhang, Ting Gao, Yilin Zhao

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c00873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Yun Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiamusi Central Hospital, Jiamus 154003, P. R. China. Hauptthemen laut MEDLINE: Ferrocyanides, Doxorubicin, Nanoparticles, Triazoles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Xiamen Municipality, Xiamen Municipal Bureau of Science and Technology, Health Commission of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined mild-temperature photothermal/chemotherapy has emerged as a highly promising modality for tumor therapy. However, its therapeutic efficacy is drastically compromised by the heat-induced overexpression of heat shock proteins (HSPs) by the cells, which resist heat stress and apoptosis. The purpose of this study was to downregulate HSPs and enhance the mild-temperature photothermal/chemotherapy effect. In detail, the colon cancer cell membrane (CT26M)-camouflaged HSP90 inhibitor ganetespib and the chemotherapeutic agent doxorubicin (DOX)-coloaded hollow mesoporous Prussian blue (HMPB) nanoplatform (named PGDM) were designed for synergistic mild photothermal/chemotherapy via HSP inhibition. In addition to being a photothermal agent with a high efficiency of photothermal conversion (24.13%), HMPB offers a hollow hole that can be filled with drugs. Concurrently, the cancer cell membrane camouflaging enhances tumor accumulation through a homologous targeting mechanism and gives the nanoplatform the potential to evade the immune system. When exposed to NIR radiation, HMPB's photothermal action (44 °C) not only causes tumor cells to undergo apoptosis but also causes ganetespib to be released on demand. This inhibits the formation of HSP90, which enhances the mild photothermal/chemotherapy effect. The results confirmed that the combined treatment regimen of mild photothermal therapy (PTT) and chemotherapy showed a better therapeutic efficacy than the individual treatment methods. Therefore, this multimodal nanoparticle can advance the development of drugs for the treatment of malignancies, such as colon cancer, and has prospects for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerrocyanidesDoxorubicinNanoparticlesTriazolesAntineoplastic AgentsColonic NeoplasmsHeat-Shock ProteinsAnimalsMiceCell Line, TumorHumansApoptosisPhotothermal TherapyHSP90 Heat-Shock ProteinsPhototherapy

Stichwörter der Autor:innen

colon cancercombinational therapyheat shock proteinshomologous targetingmild photothermal therapy

Substanzen

ferric ferrocyanideFerrocyanidesDoxorubicinTriazolesAntineoplastic AgentsHSP90 Heat-Shock ProteinsSTA 9090Heat-Shock Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology, Jiamusi Central Hospital, Jiamus 154003, P. R. China.
  • Department of Internal Medicine, School of Clinical Medicine, Jiamusi University, Jiamusi 154007, P. R. China.
  • Department of Emergency and Critical Care Center, The Second Affiliated Hospital of Guangdong Medical University, No.12 Minyou Road, Xiashan, Zhanjiang, Guangdong 524003, P. R. China.
  • Department of Pharmacy, Medical College of Guangxi University, Nanning 530004, P. R. China.
  • Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, P. R. China.
  • Department of Biomedical Engineering, Medical College of Guangxi University, Nanning 530004, P. R. China.

ORCID-Profile: Jinling Wang

Förderung

  • Natural Science Foundation of Xiamen Municipality
  • Xiamen Municipal Bureau of Science and Technology
  • Health Commission of Heilongjiang Province
  • Xiamen City

Zitieren

APA

Wang, Y., Wang, J., Ye, R., Jin, Q., Yin, F., Liu, N., Wang, Y., Zhang, Q., Gao, T., & Zhao, Y. (2024). Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c00873

Vancouver

Wang Y, Wang J, Ye R, Jin Q, Yin F, Liu N, et al. Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c00873

BibTeX
@article{Wang2024,
  author = {Wang, Yun and Wang, Jinling and Ye, Roumei and Jin, Quanyi and Yin, Fengyue and Liu, Nian and Wang, Yubo and Zhang, Quan and Gao, Ting and Zhao, Yilin},
  title = {Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c00873}
}
Kostenlos starten →